Realizing the Promise of Gene Therapy and Gene Editing: Current Challenges, Opportunities and Trends

12:15 PM - 1:30 PM (EDT), Wednesday, June 7, 2023 ・ Session Room 253ABC
Genetic therapies are transforming patients’ lives in ways unimaginable 20 years ago, and recent scientific advances with both clinical stage and commercial genetic therapies have made some previously untreatable genetic diseases now treatable. With these advances come new approaches to developing and delivering genetic medicines as well as new challenges, opportunities, and trends. Gain insights and perspectives from stakeholders with experience addressing these challenges and opportunities while bringing new types of treatments to patients. Find out what progress has been made since BIO 2022 and what opportunities are on the horizon for this exciting field.
Senior Vice President, Global Gene Therapy Business
Pfizer Inc.
Chief Medical Officer
bluebird bio
Managing Director, Co-Head of US Healthcare Investment Banking
Morgan Stanley
Director, Center for Biologics Evaluation and Research (CBER)
U.S. Food and Drug Administration
Chief Executive Officer and Founder
Chief Scientific Officer and Executive Vice President
Intellia Therapeutics